Cargando…
Measuring proliferation in breast cancer: practicalities and applications
Various methods are available for the measurement of proliferation rates in tumours, including mitotic counts, estimation of the fraction of cells in S-phase of the cell cycle and immunohistochemistry of proliferation-associated antigens. The evidence, advantages and disadvantages for each of these...
Autores principales: | Beresford, Mark J, Wilson, George D, Makris, Andreas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797032/ https://www.ncbi.nlm.nih.gov/pubmed/17164010 http://dx.doi.org/10.1186/bcr1618 |
Ejemplares similares
-
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
por: Burcombe, Russell, et al.
Publicado: (2006) -
Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer
por: Woolf, D K, et al.
Publicado: (2014) -
Update on the use of aromatase inhibitors in early-stage breast cancer
por: Kesisis, Georgios, et al.
Publicado: (2009) -
The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
por: Beresford, M J, et al.
Publicado: (2006) -
Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer
por: Masuda, Shinobu, et al.
Publicado: (2023)